A total of 20 healthy male Wistar rats (age, 2 months; weight, 250±20 g) were purchased from Shanghai SLAC laboratory Animal Co., Ltd. (Shanghai, China) and raised in the experimental animal center in Yan'an University (Yan'an, China) at a temperature of 21±1°C with 50–70% humidity, 5% CO₂ and a 12 h day-night cycle. All rats had free access to food and water. The present study was approved by the Ethics Committee of the Affiliated Hospital of Yan'an University.

Atropine eye drops (0.1%), ofloxacin eye drops (0.3%) and mydrin-P were supplied by Merck (Merck & Co., Inc., Whitehouse Station, NJ, USA). Pentobarbital sodium and lidocaine were purchased from Zhpharma (Shanghai Zhonghua Pharmaceutical Co., Ltd., Shanghai, China). IL-10 was purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). High glucose Dulbecco's modified Eagle medium (DMEM), fetal bovine serum (FBS) and penicillin-streptomycin were obtained from HyClone (GE Healthcare Life Sciences, Logan, UT, USA). Dimethyl sulfoxide (DMSO) and MTT were supplied by Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Trypsin was obtained from Sigma-Aldrich (Merck KGaA). Polyvinylidene fluoride (PVDF) membrane was purchased from Pall Life Sciences (Port Washington, NY, USA). Western blotting reagents including polyvinylidene fluoride (PVDF) membrane and Tween-20 were obtained from Beyotime Institute of Biotechnology (Shanghai, China). Peroxidase substrate for Enhanced Chemiluminescence (ECL) reagent was purchased from Amersham (GE Healthcare, Chicago, IL, USA). Rabbit anti-rat vascular endothelial growth factor (VEGF) monoclonal antibody (cat. no. 9698) and horseradish peroxidase (HRP)-conjugated immunoglobulin G goat anti-rabbit secondary antibody (cat. no. 7074) were purchased from Cell Signaling Technology, Inc., Danvers, MA, USA). IL-1β (cat. no. RLB00) and IL-6-specific (cat. no. R6000B) ELISA kits were supplied by R&D Systems, Inc. (Minneapolis, MN, USA). Caspase-3 activity detection kit was purchased from Cell Signaling Technology, Inc. SYBR^®-Green Quantitative RT-qPCR kit was from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). A Transwell chamber was purchased from Corning Incorporated (Corning, NY, USA). The microplate reader was purchased from Labsystems Diagnostics Oy (Vantaa, Finland). ABI 7700 Fast Real Time PCR was supplied by Thermo Fisher Scientific, Inc. Benchtop was purchased from Suzhou Purification Engineering Installation Co., Ltd. (Suzhou, China). A Forma incubator was purchased from Thermo Fisher Scientific, Inc.

The rat RRD model was established as previously described (22). Briefly, following 0.1% pentobarbital sodium intraperitoneal anesthesia injection, rats were placed in supine position. Atropine eye drops (0.1%) and ofloxacin eye drops (0.3%) were administered to rats for 3 days (1 drop daily) prior to the surgery. At the same time, 100 µl 0.5% Mydrin-P was used to induce mydriasis 3 days prior to surgery. Lidocaine (2%) and bupivacaine (0.75%) (Sigma-Aldrich, Merck KGaA) were applied subconjunctivally for local anesthesia. Needles (30 gauge) were used to mechanically induce retinal detachment of ~2 mm under the rim of the right eye on the sclera and retina. Needles were then inserted back into the subretinal space followed by injection of 70% sodium hyaluronate (Sigma-Aldrich, Merck KGaA) until successful induction of retinal detachment was achieved. A total of 10,000 units of gentamicin and dexamethasone (Sigma-Aldrich, Merck KGaA) were injected locally and chloramphenicol (Sigma-Aldrich, Merck KGaA) eye drops were used postoperatively to prevent infection. Eye examination was performed with an operating microscope to evaluate whether RRD was successfully induced (Fig. 1).

Rats were anesthetized with retrobulbar injections of lidocaine (2%) and the eyeballs were subsequently removed. Rats were subsequently sacrificed using cervical dislocation method. The eyeballs were washed with gentamycin and placed in DMEM. The eyeballs were cut open 3 mm posterior to the corneoscleral limbus, and the anterior segment and vitreous body were removed and discarded. The remaining tissue was digested with trypsin (0.25%) at room temperature for 10 min. The retinal neurepithelium layer was separated, removed and discarded. The retinal neurepithelium tissue was further digested with trypsin (0.25%) at 37°C for 30 min. The resulting cell suspension was centrifuged at 125 × g for 10 min at room temperature and cells (purity >90%) were cultured in DMEM medium containing 100 U/ml penicillin and 100 µg/ml streptomycin at 37°C. RPE cells in the 2nd-8th generation and logarithmic phase were used in subsequent experiments. Cells were randomly divided into four groups: One untreated Model group and three IL-10 groups, which received different concentrations of IL-10 (100, 50, and 20 mM) for 48 h at room temperature.

RPE cells in logarithmic phase were seeded onto a 96-well plate at a density of 5×l0³ cells/well and cultured for 24 h at 37°C. The cells were divided into the four aforementioned groups and treated accordingly. Following 48 h of culture, MTT (20 µl) was added to each well and incubated for 4 h at 37°C. Subsequently, DMSO (150 µl/well) was added to the plate, which was then shaken for 10 min. The absorbance value was measured at a wavelength of 570 nm. Each experiment was run in triplicate.

A total of 5×l0³ RPE cells in logarithmic phase were collected followed by centrifugation at 500 × g for 10 min at room temperature to obtain the supernatant which was used to measure IL-1β and IL-6 levels by ELISA kits according to manufacturer's instructions. A total of 50 µl diluted standard solution was added to the 96-well plate to obtain the standard curve. A total of 50 µl supernatant sample was added to each well. Following washing five times using PBS, conjugate reagent (50 µl/well) was added to the wells and incubated at 37°C for 30 min. Subsequently, reagent A (50 µl/well) and reagent B (50 µl/well) were added and the plate was incubated at 37°C for 10 min. The stop buffer (50 µl/well) was added and the absorbance value was measured at a wavelength of 450 nm. The linear regression equation of standard curve was calculated relative to the concentration of the standard substance. The sample concentration was determined from the absorbance value.

RPE cells (5×10³/ml) were digested with trypsin and centrifuged at 600 × g and 4°C for 5 min. Subsequently, lysis buffer was added into PRE cells and incubated on ice for 15 min. Following centrifugation (20,000 × g; 4°C; 5 min), 2 mM Ac-DEVD-pNA (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) was added to the suspension and the absorbance value was measured at a wavelength of 405 nm.

Total RNA was extracted from RPE cells (5×10³/ml) using TRIzol (Thermo Fisher Scientific, Inc.); and reverse transcribed to cDNA using SYBR^®-Green Quantitative RT-qPCR kit (Sigma-Aldrich; Merck KGaA) according to manufacturer's protocol. Primers were designed using Primer Premier software version 6.0 (Premier Biosoft International, Palo Alto, CA, USA) and synthetized by Invitrogen (Thermo Fisher Scientific, Inc.); primer sequences are presented in Table I. qPCR reactions were performed at 95°C for 1 min, followed by 35 cycles at 92°C for 30 sec, 58°C for 45 sec, and 72°C for 35 sec. GAPDH was selected as an internal reference gene. The relative expression level was calculated using the 2^−∆∆Cq method (23) and represented as a fold changes relative to GAPDH.

Total protein was extracted from RPE cells (5×10³/ml) on ice using the radioimmunoprecipitation assay buffer for 15–30 min. Following ultrasonications 4 times at 37°C, 5 sec each, and centrifugation at 4°C and 10,000 × g for 15 min, the protein solution was transferred to a new Eppendorf tube. RPE proteins were stored at −20°C following quantification using Pierce BCA Protein Assay kit (Thermo Fisher Scientific, Inc.). Proteins were loaded into 10% SDS-PAGE (20 µg/well) at 100 mA for 1.5 h and transferred to a PVDF membrane. Following blocking with 5% skim milk at room temperature for 2 h, the membrane was incubated with primary antibodies against VEGF (1:1,000) and β-actin (1:2,000) at 4°C overnight. The membrane was washed with PBS with 0.05% Tween-20 and further incubated with HRP-conjugated goat anti-rabbit secondary antibody at 1:2,000 for 30 min at room temperature. Protein bands were visualized with ECL reagent for 1 min and developed. β-actin used as a loading control and to normalize expression in densitometric analysis. The membrane was scanned with an image processing system and analyzed using Quantity One 1-D Analysis Software version 4.6.5 (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Each experiment was repeated four times.

RPE cell suspensions were collected at the logarithmic phase (density of cells, 5×10³/ml) under 12 h starvation culture in cell starvation medium (Sigma-Aldrich; Merck KGaA) following treatments with different concentrations of IL-10 and subsequently added into upper part of the Transwell chamber containing DMEM medium. 10% FBS was added into the lower part of the chamber. Following incubation at 37°C for 24 h, cells in the upper membrane were removed using a pipette tip or cotton tipped applicator and RPE cells were stained with 0.1% crystal violet at room temperature for 10 min and observed under an inverted microscope. Five fields were selected for each staining and cell numbers were counted.

SPSS software (version 19.0; IBM Corp., Armonk, NY, USA) was used for data analysis. All data were presented as the mean ± standard deviation. Intergroup differences were analyzed by analysis of variance. P<0.05 was considered to indicate a statistically significant difference.

Eye examination was performed with an operating microscope to demonstrate the interruption in retinal neurepithelium layer, apophysis and detachment of RPE, and opaque dark area of fluid, suggesting that RRD was successfully induced (Fig. 1). An MTT assay was used to evaluate the effects of IL-10 on RPE cell proliferation in RRD. All three concentrations of IL-10 (20, 50 and 100 µM) significantly inhibited RPE cell proliferation compared with the untreated Model group (P<0.05; Fig. 2); this inhibitory effect on cell proliferation appeared to be in a dose-dependent manner.

Caspase-3 activity was measured to evaluate the effects of varying concentrations of IL-10 on apoptotic activity in RPE cells from RRD. IL-10 treatment significantly increased caspase-3 activity compared with the Model group (P<0.05; Fig. 3), and this effect was in a dose-dependent manner. These results indicated that IL-10 may facilitate RPE cell apoptosis, which may subsequently serve an inhibitory role on RRD progression.

ELISA was used to measure the abundance of inflammatory cytokines IL-1β and IL-6 in the supernatant of RPE cells from RRD. IL-10 treatments significantly suppressed expression of IL-1β and IL-6 in RPE cells derived from RRD (P<0.05 vs. Model; Fig. 4), and this reduction was dose-dependent. These results suggested that IL-10 inhibited inflammatory cytokine secretion from RPE.

The Transwell assay was used to determine the effects of IL-10 on RPE cell migration in RRD. IL-10 expression significantly restrained RPE migration in RRD compared with the untreated model group (P<0.05), and the effect was dose dependent (Fig. 5A and B). These results suggested that IL-10 may regulate RPE cell migration in RRD.

RT-qPCR and western blotting were used to analyze the effects of different concentrations of IL-10 on VEGF mRNA and protein expression in RPE cells from RRD. It was demonstrated that the IL-10 treatments significantly downregulated VEGF mRNA and protein expressions in RPE cells from RRD in a dose-dependent manner, compared with untreated Model cells (P<0.05; Fig. 6).